Parallax Volatility Advisers, L.P. Organon & Co. Transaction History

Parallax Volatility Advisers, L.P.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$10.95 - $17.32 $10,818 - $17,112	988 New	988 $14,000
Q4 2021 Feb 14, 2022	SELL	$28.67 - $37.13 $426,867 - $552,828	-14,889 Reduced 62.31%	9,006 $274,000
Q3 2021 Nov 15, 2021	BUY	$28.63 - $35.64 $684,113 - $851,617	23,895 New	23,895 $784,000
Q3 2021 Nov 15, 2021	SELL	$28.63 - $35.64 $278,369 - $346,527	-9,723 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$28.45 - $38.0 $276,619 - $369,474	9,723 New	9,723 $294,000

794

193M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $4.11B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.